Related Experiment Video
Updated: Oct 18, 2025

Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
Published on: May 26, 2023
Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers
Tsuguhisa Nakayama1,2, Ivan T Lee1,3,4, Sizun Jiang4,5
1Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, 801 Welch Road, Stanford, CA, USA.
Abstract:
Understanding viral tropism is an essential step toward reducing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission, decreasing mortality from coronavirus disease 2019 (COVID-19) and limiting opportunities for mutant strains to arise. Currently, little is known about the extent to which distinct tissue sites in the human head and neck region and proximal respiratory tract selectively permit SARS-CoV-2 infection and replication. In this translational study, we discover key variabilities in expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2), essential SARS-CoV-2 entry factors, among the mucosal tissues of the human proximal airways. We show that SARS-CoV-2 infection is present in all examined head and neck tissues, with a notable tropism for the nasal cavity and tracheal mucosa. Finally, we uncover an association between smoking and higher SARS-CoV-2 viral infection in the human proximal airway, which may explain the increased susceptibility of smokers to developing severe COVID-19. This is at least partially explained by differences in interferon (IFN)-β1 levels between smokers and non-smokers.
Insights
This study reveals SARS-CoV-2 tropism in head and neck tissues, with higher infection in smokers linked to lower interferon levels. Understanding viral entry factors like ACE2 and TMPRSS2 is key to reducing COVID-19 spread and severity.
Area of Science:
- Virology
- Respiratory Medicine
- Immunology
Background:
- Understanding SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) viral tropism is crucial for controlling COVID-19 (coronavirus disease 2019) transmission and severity.
- Limited knowledge exists regarding SARS-CoV-2 infection and replication selectivity in human head, neck, and proximal airway tissues.
- Key viral entry factors, angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2), play a role in SARS-CoV-2 infection.
Purpose of the Study:
- To investigate SARS-CoV-2 tropism across various mucosal tissues in the human head and neck region and proximal respiratory tract.
- To identify variations in ACE2 and TMPRSS2 expression in these tissues and their correlation with viral infection.
- To explore the association between smoking and SARS-CoV-2 infection susceptibility and severity in the proximal airway.
Main Methods:
- Translational research study examining mucosal tissue samples from the human head and neck and proximal respiratory tract.
- Analysis of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) expression levels.
- Detection and quantification of SARS-CoV-2 infection in tissue samples.
- Assessment of interferon (IFN)-β1 levels in smokers and non-smokers.
Main Results:
- Significant variability in ACE2 and TMPRSS2 expression was observed among proximal airway mucosal tissues.
- SARS-CoV-2 infection was detected in all examined head and neck tissues, with pronounced tropism for the nasal cavity and tracheal mucosa.
- A positive association was found between smoking and increased SARS-CoV-2 viral infection in the proximal airway.
- Lower interferon (IFN)-β1 levels were noted in smokers compared to non-smokers, potentially explaining increased susceptibility to severe COVID-19.
Conclusions:
- The study identifies specific tropism of SARS-CoV-2 within the human head and neck and proximal airway, highlighting the nasal cavity and trachea.
- Variations in ACE2 and TMPRSS2 expression contribute to differential viral susceptibility.
- Smoking is associated with higher SARS-CoV-2 infection and potentially more severe COVID-19 outcomes, possibly due to altered interferon responses.
More Related Videos
09:07Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research
Published on: July 12, 2024
06:07Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...